Key stats
About YINHUA FUND MANAGE
Home page
Inception date
Mar 20, 2020
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Yinhua Fund Management Co., Ltd.
ISIN
CNE1000045X7
The Fund adopts passive indexation investment, closely tracks the index of the underlying object, and seeks tracking deviation and tracking errMinimize
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
159992 fund flows account for 162.76 K CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 159992 doesn't pay dividends to its holders.
159992 shares are issued by Yinhua Fund Management Co., Ltd. under the brand Yinhua. The ETF was launched on Mar 20, 2020, and its management style is Passive.
159992 expense ratio is 0.55% meaning you'd have to pay 0.55% of your investment to help manage the fund.
159992 follows the CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159992 price has risen by 13.24% over the last month, and its yearly performance shows a 42.97% increase. See more dynamics on 159992 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −8.61% over the last month, have fallen by −8.61% over the last month, showed a −11.34% decrease in three-month performance and has decreased by −41.10% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −8.61% over the last month, have fallen by −8.61% over the last month, showed a −11.34% decrease in three-month performance and has decreased by −41.10% in a year.
159992 trades at a premium (0.13%) meaning the ETF is trading at a higher price than the calculated NAV.